Managing Diabetes
University of California Audio Podcasts (Audio) · UCTV: UC San Francisco
August 8, 202557m 2s
Audio is streamed directly from the publisher (podcast.uctv.tv) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Robert Baron outlines major updates in type 2 diabetes care, emphasizing that blood sugar control alone does not significantly reduce cardiovascular risk, though it helps prevent microvascular complications. New guidelines now prioritize medications with proven cardiovascular and kidney benefits—GLP-1 receptor agonists and SGLT2 inhibitors—over traditional first-line therapy like metformin. Baron explains how these newer drugs not only lower blood sugar but also reduce the risk of heart attack, stroke, kidney disease, and heart failure, with added benefits such as weight loss. He also covers changes in screening, diagnosis, blood pressure goals, and individualized treatment strategies based on age, comorbidities, and patient preferences. [Health and Medicine] [Show ID: 40756]
Topics
diabeteshealthmedicinedoctormetabolicweightillnessinsulinbloodsugarGLP1SGLT2heartkidneystrokemetforminDiabetes40756